Innovating Works

EMBUTIDOS DEL CENTRO

Activa
HEPCAN: A Humanized Monoclonal Anti Claudin1 Antibody anti CLDN1 mAb for Treatment of Hepatocellular Carci... INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un H2020: ERC-2019-PoC Hepatocellular carcinoma is the most frequent primary liver cancer and owing to its very aggressive nature is amongst the leading cause of c...
2019-08-05 - 2021-09-30 | Financiado
Ctrl-ImpAct: Control of impulsive action UNIVERSITEIT GENT tramitó un H2020: ERC-2017-COG Adaptive behaviour is typically attributed to an executive-control system that allows people to regulate impulsive actions and to fulfil lon...
2018-02-08 - 2024-05-31 | Financiado
iEBDD: A Software Interface for Interactive Ensemble Based Drug Design THE UNIVERSITY OF EDINBURGH tramitó un H2020: ERC-2016-PoC The ERC project EBDD was funded to bring about a new generation of computer algorithms to implement accurate molecular simulations of biomol...
2017-06-23 - 2018-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.